Compound Evidence File
#EC-2026-0102
Sustanon Blend Raw
Filed under Raw Materials. The bureau holds 99 laboratory returns for this compound from 31 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
31 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 8 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 4 | 10.0 | 9.9 | 10.0 | 11 Mar 2026 | 13 Jun 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 4 | 10.0 | 10.0 | 10.0 | 5 Apr 2026 | 11 Jun 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 10.0 | 9.9 | 10.0 | 7 Mar 2026 | 11 Jul 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 4 | 10.0 | 9.9 | 10.0 | 14 May 2026 | 7 Jun 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 3 | 10.0 | 9.9 | 10.0 | 2 Jun 2026 | 8 Jul 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 3 | 10.0 | 9.9 | 10.0 | 14 Feb 2026 | 3 Jul 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 4 | 9.9 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 4 | 9.9 | 9.9 | 10.0 | 28 Mar 2026 | 3 Jul 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 4 | 9.9 | 9.9 | 10.0 | 26 Feb 2026 | 27 Jun 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 4 | 9.9 | 9.9 | 10.0 | 12 Feb 2026 | 26 Jun 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 4 | 9.9 | 9.9 | 10.0 | 28 Jan 2026 | 2 Jul 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 3 | 9.9 | 9.9 | 10.0 | 25 Apr 2026 | 4 Jun 2026 |
| BachemCASE #VI-2026-0314 | A | 2 | 9.9 | 9.9 | 9.9 | 9 Feb 2026 | 8 Jun 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 2 | 9.9 | 9.9 | 10.0 | 27 Mar 2026 | 18 Jun 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 3 | 8.8 | 7.7 | 9.7 | 24 May 2026 | 24 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 7 | 8.7 | 7.0 | 10.0 | 21 May 2026 | 21 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 3 | 8.7 | 7.5 | 9.7 | 24 May 2026 | 24 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 8 | 8.5 | 6.0 | 10.0 | 23 May 2026 | 23 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 5 | 8.0 | 7.0 | 9.3 | 24 May 2026 | 24 May 2026 |
| Peptide-SCASE #VI-2026-0111 | X | 4 | 7.9 | 5.7 | 10.0 | 25 Apr 2025 | 21 May 2026 |
| Top PeptideCASE #VI-2026-0721 | X | 1 | 7.5 | 7.5 | 7.5 | 3 Jul 2025 | 3 Jul 2025 |
| LN PeptidesCASE #VI-2026-0781 | X | 1 | 7.4 | 7.4 | 7.4 | 8 Jul 2025 | 8 Jul 2025 |
| M-PeptidesCASE #VI-2026-0442 | X | 1 | 6.8 | 6.8 | 6.8 | 9 Jun 2025 | 9 Jun 2025 |
| Simple PeptideCASE #VI-2026-0782 | X | 2 | 6.6 | 4.8 | 8.4 | 13 Feb 2025 | 25 May 2026 |
| Wolverine PeptidesCASE #VI-2026-0262 | X | 1 | 6.1 | 6.1 | 6.1 | 17 Dec 2024 | 17 Dec 2024 |
| YimeiCASE #VI-2026-0081 | X | 2 | 5.6 | 4.6 | 6.6 | 25 Apr 2025 | 19 Jan 2026 |
| Hangzhou Youngpeptide Biotechnology HYBCASE #VI-2026-0347 | X | 1 | 5.6 | 5.6 | 5.6 | 2 Jul 2025 | 2 Jul 2025 |
| PeptiLab ResearchCASE #VI-2026-0267 | X | 1 | 4.5 | 4.5 | 4.5 | 13 Feb 2025 | 13 Feb 2025 |
| Amino AsylumCASE #VI-2026-0828 | X | 1 | 3.9 | 3.9 | 3.9 | 28 Mar 2025 | 28 Mar 2025 |
| Guangzhou Lengiuanhuang CosmeticsCASE #VI-2026-0228 | X | 1 | 3.0 | 3.0 | 3.0 | 6 May 2025 | 6 May 2025 |
Open any subject to view the batch-level evidence for Sustanon Blend Raw alone.